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Abstract
African trypanosomes of the Trypanosoma brucei species are extracellular protozoan parasites that cause the deadly disease
African trypanosomiasis in humans and contribute to the animal counterpart, Nagana. Trypanosome clearance from the
bloodstream is mediated by antibodies specific for their Variant Surface Glycoprotein (VSG) coat antigens. However, T. brucei
infection induces polyclonal B cell activation, B cell clonal exhaustion, sustained depletion of mature splenic Marginal Zone
B (MZB) and Follicular B (FoB) cells, and destruction of the B-cell memory compartment. To determine how trypanosome
infection compromises the humoral immune defense system we used a C57BL/6 T. brucei AnTat 1.1 mouse model and
multicolor flow cytometry to document B cell development and maturation during infection. Our results show a more than
95% reduction in B cell precursor numbers from the CLP, pre-pro-B, pro-B, pre-B and immature B cell stages in the bone
marrow. In the spleen, T. brucei induces extramedullary B lymphopoiesis as evidenced by significant increases in HSC-LMPP,
CLP, pre-pro-B, pro-B and pre-B cell populations. However, final B cell maturation is abrogated by infection-induced
apoptosis of transitional B cells of both the T1 and T2 populations which is not uniquely dependent on TNF-, Fas-, or
prostaglandin-dependent death pathways. Results obtained from ex vivo co-cultures of living bloodstream form
trypanosomes and splenocytes demonstrate that trypanosome surface coat-dependent contact with T1/2 B cells triggers
their deletion. We conclude that infection-induced and possibly parasite-contact dependent deletion of transitional B cells
prevents replenishment of mature B cell compartments during infection thus contributing to a loss of the host’s capacity to
sustain antibody responses against recurring parasitemic waves.
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Introduction
Trypanosoma brucei is a highly antigenically variable uniflagellate
protozoan of which the subspecies T. b. gambiense and T. b.
rhodesiense cause Human African Trypanosomiasis (HAT), also
called Sleeping Sickness. In addition the parasite infects domestic
animals, contributing to Nagana, which is a fatal disease of
livestock in sub-Saharan Africa. T. brucei is transmitted in tsetse fly
saliva and lives and replicates in blood, lymph and interstitial fluids
of its mammal hosts protected from lytic plasma components by a
coat of variable surface glycoprotein (VSG). The surface coat of a
T. brucei parasite consists of 10
7 identical densely packed VSG
molecules which can be varied among a possibly unlimited
repertoire of coat types via a mechanism called antigenic variation
[1–5]. Clearance of T. brucei and other African trypanosomes from
the host blood stream is mainly mediated by VSG specific
antibodies [6–8]. T. brucei parasites have been shown to (i) deplete
marginal zone and follicular B cells from the spleen [9] , (ii) induce
non-specific, polyclonal B cell activation leading to clonal
exhaustion [10–12], and (iii) cause a general decrease in bone
marrow cells [13] consistent with a negative impact on
lymphopoiesis and erythropoiesis. Infection of trypanosomiasis-
susceptible hosts with African trypanosomes has been shown to
compromise host humoral immune competence resulting in the
loss of B cell responsiveness to new antigens and of recall responses
to previously encountered antigens, including trypanosome VSGs
and vaccines [9]. Hence, vaccination against trypanosomiasis has
so far never been successful in a natural infection setting.
B2 B cell lineage development under normal conditions occurs
via a series of bone marrow (BM) stromal cell facilitated processes
that begin within the hematopoietic stem cell pool and proceed in
hierarchical steps of lineage commitment [14,15]. Hematopoietic
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progenitors (MLP) and lymphocyte primed multi lineage progen-
itors (LMPP) that no longer self renew. LMPP, in turn, give rise to
common lymphoid progenitors (CLP), which have been shown to
sustain both T and B lymphopoiesis, although these lineages may
diverge within the CLP. CLP give rise to several types of precursor
cells, including pre-pro-B cells [16,17]. B lymphopoiesis then
proceeds in the bone marrow yielding several developmental
stages of pre-pro-B, pro-B, pre-B and eventually immature B cells,
which show a high expression of the IgM form of the antigen
receptor and low or no expression of the IgD maturation marker
[18,19]. To complete their development, immature B cells migrate
through the periphery, however only 10% reaches the spleen as
transitional B cells of the T1 type. Important is the fact that under
inflammatory immune conditions, BM lymphopoiesis is often
severely reduced, and is compensated for by a splenic cell
differentiation process that involves the same B-cell differentiation
steps, referred to as extramedullary lymphopoiesis [20,21]. Once
the transitional T1 stage has been reached, B cells develop further
into T2 transitional B cells that in turn can mature into either
Marginal Zone B (MZB) cells or Follicular B (FoB) cells [22]. T2
cells can also give rise to T3 transitional B cells, but the latter don’t
give rise to mature B cells, due to being hyper-responsive to
stimulation through their BCR [23]. Each of these populations is
distinguished by a unique set of cell surface antigens, allowing
monoclonal antibody (mAb) phenotyping by multicolor flow
cytometry [24–26]. Using this approach, Radwanska et al.
reported that the splenic MZB and FoB cell populations become
rapidly depleted in T. brucei-infected mice and do not recover [9].
Since these findings suggest an impaired replacement of mature B-
cells during infection, we have now investigated B cell develop-
ment, maturation and cell death of various B-cell populations in
T. brucei-infected mice.
B-lymphocyte cell death in the context of inflammation and
infection has been attributed in the past to several major
mechanisms that include TNF-TNFR1 and Fas/Fas-L induced
apoptosis, prostaglandin triggered cell death and BCR-cross-linking
in the absence of proper T-cell help [20,27–32]. With respect to
African Trypanosomiasis, none of these aspects have been
addressed so far, despite the crucial need for an effective B-cell
compartment for parasitemia control. In contrast, their role and
modulation during intracellular Trypanosoma cruzi infections is better
documented, showing that: (i) in the absence of TNF-TNFR1
signaling, susceptibility to infection increases and coincides with
abnormal B-cell differentiation in secondary lymphoid tissues [33].
(ii) CD95/FasL interaction between B cells can mediate the
fratricide of IgG+ B lymphocytes [27], and (iii) myeloid cell-derived
prostaglandins contribute to infection-associated apoptosis of
immature B cells in a Fas-FasL independent manner [28].
Programmed cell death can be induced by a number of death
factors, including Fas-FasL interaction [34,35] and the TNF-TNF-
R1 apoptosis pathway [36,37]. With respect to the latter, it has been
well established that (i) T. brucei infections induce severe inflamma-
tory disease in susceptible hosts leading to the excessive production
of pro-inflammatory factors including TNF and prostaglandins
[38–42], and (ii) that excess induction of TNF negatively affects
various lymphoid compartments [20]. In contrast to TNF, to date
no information on the role of Fas has been reported in a T. brucei
infection setting. The Fas apoptosis pathway is normally important
in both the regulation of the immune response as well as T and B
lymphocyte homeostasis [35]. Therefore, Fas-FasL mediated
apoptosis plays a critical role in the mechanism for negative
selection of B cells [43–45] and for the establishment of the B cell
repertoire in the memory compartment [46]. Following activation,
B cellscanrapidly upregulate both FasandFasL expression [47,48],
but the control of B lymphocyte expansion appears mainly to be
regulated by FasL-expressing T cells [47].
Here we investigate the contributions of different mechanisms to
T. brucei-induced abrogation of B cell development and infection-
associated B cell apoptosis. Our results show that following T.
brucei infection, B lymphopoiesis is truncated in the bone marrow
and compensatory extramedullary B lymphopoiesis is induced (but
not completed) in the spleen. Splenic B lymphopoiesis up to the
stage of immature B cells was triggered but final development was
severely limited by apoptosis of transitional B cells, thus preventing
replenishment of mature B2 B cells. Despite the pro-inflammatory
immune environment induced by experimental T. brucei infections,
these events occurred independent from TNF-TNF-R1, Fas-Fas-L
and prostaglandin-mediated pathways. Interestingly, in an ex vivo
setting in which naı ¨ve or infection-derived splenocytes were co-
cultured with living bloodstream form trypanosomes, transitional
B-cell apoptosis was only observed when cell-cell contact between
lymphocytes and parasites occurred. This observation corrobo-
rates the previous findings from Radwanska et al. that showed that
trypanosomes can induce contact dependent cell death in anti-
VSG hybridoma B-cells [49]. Using a Trans-well co-culture
system, or a VSG specific Nanobody, i.e. a variable heavy chain
fragment of a single chain camelid antibody devoid of its Fc part
[50], we now show that preventing direct contact between the
trypanosome surface coat and transitional B-cells results in an
abrogation of infection-induced apoptosis in the ex vivo setting.
Results
Impaired B lymphopoiesis in T. brucei infected mice
T. brucei infections in mice have been shown to compromise host
humoral immune competence and to induce the loss of specific
mature B cell populations in the spleen [9]. However, little is
known about how B lymphopoiesis in the bone marrow is affected
during T. brucei infection. Here, B lymphopoiesis has been
examined using a C57BL/6 mouse T. brucei AnTat 1.1E infection
Author Summary
African trypanosomiasis caused by Trypanosoma brucei
species is fatal in both humans and animals and cannot be
combated by vaccination because of extensive parasite
antigenic variation. Effective trypanosome control and
clearance from the bloodstream involves the action of
antibodies specific for the parasite’s highly diverse variable
surface glycoprotein antigens. However, experimental
infections in mice have shown that trypanosomiasis elicits
a rapid process of B cell exhaustion and loss of protective
antibody responses. Indeed, both marginal zone B cells,
the first line of defense against blood-borne pathogens
like T. brucei parasites, and follicular B cells, which are the
major source for developing high-affinity antibody-pro-
ducing plasma cells and memory B cells, become depleted
during infection. In addition, existing B-cell memory, both
against parasite antigens and non related pathogens, is
destroyed early on in infection. Here, we demonstrate that
during infection, B cell development is decreased in the
bone marrow and early B cell development is taken over
by the spleen. However, full maturation of developing B
cells is abrogated by the occurrence of transitional B cell
apoptosis. This impairs the replenishment of the mature
marginal zone and follicular B cell pools and prevents the
buildup of protective immunity against successive para-
sitemic waves.
T. brucei Infection-Induced B Cell Dysfunction in Mice
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and a median infection survival time of 35 days [51]. Bone
marrow and spleen cells were isolated at different time points of
infection and prepared for cellular characterization by multicolor
flow cytometry as described in Table 1 and shown in Figure S1, S2
and S3. As presented in Figure 1, the number of very early
progenitors, i.e., HSC-LMPP was minimally affected, showing
only a transient reduction on day 20 p.i. Subsequent bone marrow
B lymphopoiesis was severely affected in T. brucei infected mice,
with major declines in all bone marrow B cell developmental
stages starting with the CLP fraction. A drop in the number of
CLP progenitors was detected on day 10 p.i. and this cell
population remained severely depleted thereafter. The pre-pro-B
cell population showed a 50% reduction by day 20 p.i., while the
subsequent B-cell maturation stage i.e. the pro-B, pre-B and
immature B cell populations reached more than 95% depletion by
day 10 p.i. and failed to recover throughout the further course of
infection. Combined, these results show that at the end stage of
differentiation in the bone marrow, B cell numbers are severely
depleted.
T.brucei infection induces extramedullary lymphopoiesis
in the spleen
Inflammation in general has been described to induce
mobilization of immature bone marrow lymphocytes [20].
Because T. brucei infection is characterized by a strong type 1
Figure 1. B dyslymphopoiesis in bone marrow during T. brucei infection. (A) Bone marrow cells from non-infected mice and mice infected
with T. brucei for 6–30 days were stained for surface markers commonly used to define developing B cells, as described in table 1 and analyzed using
FACS. Data are represented as mean of three mice per group 6 SEM, three independent repeat experiments were performed and statistics are
compared to uninfected controls (*) p,0,05, (**) p,0,01. (B) Immature B cells were detected as (Lin
2B220
+IgM
+CD43
lo/2 AA4.1
+CD19
+) cells in
uninfected mice (left panel) versus infected mice on day 10 p.i. (right panel).
doi:10.1371/journal.ppat.1002089.g001
Table 1. Differentiation antigen phenotypes of developing
and mature B2 B cells.
Suface marker phenotype
HSC/LMPP Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
2, IL-7r
2, ckit
+
CLP Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
2, ckit
2, AA4.1
+, IL-7r
+
pre-pro-B Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
+, AA4.1
+,I g M
2, CD19
2, CD43
hi
pro-B Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
+, AA4.1
+,I g M
2, CD19
+, CD43
hi
pre-B Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
+, AA4.1
+,I g M
2, CD19
+, CD43
lo/2
immature B Lin
2 (Ter119, CD3e, CD11b, Gr1, NK1.1),
B220
+, AA4.1
+,I g M
+, CD19
+, CD43
lo/2
T1 transitional B220
+, AA4.1
+,I g M
hi, CD23
2
T2 transitional B220
+, AA4.1
+,I g M
hi, CD23
+
T3 transitional B220
+, AA4.1
+,I g M
lo, CD23
+
MZB B220
+, AA4.1
2, CD1d
hi
FoB B220
+, AA4.1
2, CD1d
lo
B lymphocyte subsets (left column) were identified and defined based on flow
cytometric analysis using surface expression of specific antigens (right column).
doi:10.1371/journal.ppat.1002089.t001
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precursors may result in the appearance of developing B cells in
the spleen. Cells were harvested from the spleen at different time
points of infection and a multicolor flow-cytometric analysis was
performed according to Table 1. As shown in Figure 2, T. brucei
infection induced an increase in HSC-LMPP fractions in the
spleen by day 10 p.i. In addition, there was a significant rise in
CLP, pre-pro-B, pro-B and pre-B cell numbers in the spleen on
day 10 p.i., coinciding with the drastic losses of B cell precursors
from the bone marrow. While pre-pro-B, pro-B and pre-B cell
numbers remained significantly elevated in the spleen by day 20
p.i., these populations returned to pre-infection levels towards the
end of infection (day 30 p.i.). In contrast, while there was no early
stage decrease in immature B cells in the spleen, there was a
significant loss of this population towards the end of infection.
T. brucei infection causes depletion of transitional B cells
in the spleen through induction of apoptosis
In contrast to the elevation in early B cell developmental stages
observed in the spleen, Radwanska et al. [9] have reported
depletion of mature marginal zone and follicular B cells suggesting
impaired replacement. Therefore, B cell development at the
transitional B cell stage in the spleen was examined here, as these
cells provide the link between the immature B cell stage and the
mature marginal zone and follicular B cell stages. Flow cytometric
analysis of the T1, T2 and T3 transitional B cell populations of T.
brucei infected mice (Figure 3) revealed a transient increase in
transitional B cells numbers that however rapidly faded towards
day 10 p.i. On days 20 and 30 p.i. the number of transitional T2
and T3 B cells was significantly decreased compared to uninfected
control mice.
To address whether apoptosis is contributing to the depletion of
transitional B cells in the spleen, the amount of active caspases-1,
23, 24, 25, 26, 27, 28 and 29 inside the transitional T1, T2
and T3 B cells was measured at different time points of infection
by flow cytometry (Figure 4A). Although infection did induce
apoptosis in both the T1 and T2 transitional B cell population, the
T3 population only showed a temporary increase of caspase
activation after the first week of infection (Figure 4B). The
elevation in levels of caspases in transitional B cells coincided with
the contraction of these B cell populations between days 6 and 10
p.i. (Figure 3A), i.e., immediately following peak parasitemia
(8610
7 T. brucei/ml blood). In the model used here, infections are
initiated with 5610
3 T. brucei AnTat 1.1 and remission of the first
parasitemic wave occurs between 6 and 7 days p.i. [41]. It is
noteworthy that when the infection was initiated with 10
8 T. brucei
AnTat 1.1, peak parasitemia and wave remission occurred at 4
days p.i. (data not shown) and transitional B-cell apoptosis was
observed as early as 3 days p.i. (Figure 5). These observations
suggest a direct link between levels of parasitemia and the kinetics
of induction of splenic T1/2 B-cell apoptosis. Combined, these
data indicate the induction of apoptosis in both T1 and T2
Figure 2. Extramedullary B lymphopoiesis in spleen during T. brucei infection. (A) Spleens cells from non-infected mice and mice infected
with T. brucei for 6–30 days were stained for surface markers commonly used to define developing B cells as described in table 1 and analyzed using
FACS. Data are represented as mean of three mice per group 6 SEM, two independent repeat experiments were performed and statistics are
compared to uninfected controls (*) p,0,05, (**) p,0,01, (***) p,0,001. (B) Pre-pro-B and Pro-B cells were detected as (Lin
2B220
+IgM
+CD43
hi) and
respectively AA4.1
+CD19
2 or AA4.1
+CD19
+ in uninfected mice (left panel) versus infected mice on day 10 p.i. (right panel).
doi:10.1371/journal.ppat.1002089.g002
T. brucei Infection-Induced B Cell Dysfunction in Mice
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parasitemia. The transitional B cells would, under normal
conditions, give rise to the continuous replenishment of marginal
zone and follicular B cell populations, but clearly are unable to do
so in the infected mice.
T. brucei infection-induced apoptosis of transitional B
cells occurs independently of TNF and Fas
Experimental T. brucei infections induce high circulating levels of
TNF [38], a host cytokine that has been reported to be involved
in the induction of immunopathology during T. brucei infections
[38–42]. Furthermore, TNF is known to be a potent inducer of
apoptosis through the TNF-R1 signal pathway. Therefore, to
examine the possibility of TNF-mediated apoptosis of T1 and T2
transitional B cells, TNF
2/2 mice were infected with T. brucei and
the number of T1 and T2 transitional B cells in the spleen was
examined at different time points of infection. Figure 6 illustrates
that on day 10 p.i. WT mice and TNF
2/2 mice both suffered
from similar levels of transitional T1 and T2 B cell depletion.
While on day 20 p.i. a temporary recovery of T1 transitional B
cells occurred only in the TNF
2/2 mice, the same final level of
75% reduction in both T1 and T2 transitional B cells was
observed in WT as well as TNF
2/2 mice towards the end of
infection. As an additional control, apoptosis of transitional B cells
was recorded using the poly-capase activation FACS analysis
outlined above. Here, the percentage of T1 and T2 B cells
undergoing apoptosis in T. brucei-infected TNF
2/2 as well as
TNF-R1
2/2 mice equaled the results reported for WT mice (data
not shown).
Next, the expression of the death receptor Fas (CD95) on T1
and T2 transitional B cells, and the potential involvement of the
Fas-FasL apoptosis pathway were analyzed at different time points
of infection. Control T1 and T2 transitional B cells express low,
but detectable levels of Fas on their surface. During infection
however, there was a strong increase in the level of Fas expression
on the surface of both T1 and T2 transitional B cells, as shown
here for days 8, 10, 14 and 20 p.i., (Figures 7A and B). The
increase in surface Fas expression coincided with elevated caspases
activity (Figure 4) and with the loss of transitional B cells from the
spleen (Figure 6). Interestingly, also in TNF
2/2 mice as well as
TNF-R1
2/2 mice, the increase in Fas expression on both T1 and
T2 transitional B-cells preceded the rapid loss of these cells from
the spleen further suggesting a correlation between the up-
regulation of surface-expressed Fas and the trypanosomiasis-
associated destruction of the transitional B-cell compartment
(Figure S4).
If apoptosis of transitional B cells in T. brucei-infected mice is
mediated through Fas, then the loss of the cells would be expected
to be reduced in mice with constitutively low Fas expression.
However, this proved not to be the case as the extent and kinetics
of transitional B cell loss following infection of lpr mice with T.
brucei AnTat 1.1 was the same as in wild type mice (data not
shown). In addition, if apoptosis were to be mediated through Fas
in wild type mice, it would be expected to be ameliorated by
blocking the activation of Fas by its ligand, FasL, through
administration of neutralizing anti-FasL antibody [27]. However,
this also proved not to be the case. Indeed, mice infected with T.
brucei and treated by i.v. injection with 100 mg of anti-FasL
antibody on days 4, 5 and 6 p.i. did not manifest a measurable
Figure 3. Depletion of transitional B cells in spleen during T. brucei infection. (A) Spleens cells from non-infected mice and mice infected
with T. brucei for 6–30 days were stained for surface markers commonly used to define transitional T1, T2 and T3 B cells and analyzed using FACS.
Data are presented as mean of three mice per group 6 SEM, three independent repeat experiments were performed and statistics are compared to
uninfected controls (**) p,0,01. (B) Transitional T1, T2 and T3 B cells were detected as (AA4.1
+B220
+) and respectively IgM
+CD23
2, IgM
+CD23
+ and
IgM
loCD23
+ in uninfected mice (left FACS panel) and infected mice on day 6 p.i. (middle FACS panel) and day 20 p.i. (right FACS panel).
doi:10.1371/journal.ppat.1002089.g003
T. brucei Infection-Induced B Cell Dysfunction in Mice
PLoS Pathogens | www.plospathogens.org 5 June 2011 | Volume 7 | Issue 6 | e1002089alteration in transitional B cell loss from the spleen (Figure 8a), nor
did the remaining transitional B-cells in these mice exhibit a
change in their caspase activity profile (Figure 8b) relative to mice
receiving a control immunoglobulin treatment. Thus, while the
occurrence of transitional B cell apoptosis after infection with T.
brucei coincides with an increased expression of the death receptor
Fas on the surface, apoptosis of transitional B cells could not be
prevented by the anti-FasL antibody treatment used here.
Figure 4. T. brucei infection-induced apoptosis of transitional B cells. Spleens cells from uninfected control mice and mice infected with T.
brucei were stained for surface markers commonly used to define transitional T1, T2 and T3 B cells (as described in table 1) and the amount of active
caspases 21, 23, 24, 25, 26, 27, 28 and 29 was measured by intracellular staining using the FAM poly caspases assay kit and flowcytometry. (A)
Representative histogram of uninfected controls (grey line) versus a day 10 p.i. (black line). (B) Percentage of apoptotic cells within T1, T2 and T3
transitional B cell populations in uninfected controls versus infected mice on day 8, 10 and 20 p.i. Data are represented as mean of three mice per
group 6 SEM and two independent repeat experiments were performed (*) p,0,05, (**) p,0,01.
doi:10.1371/journal.ppat.1002089.g004
Figure 5. Apoptosis of transitional B cells in vivo. Control mice and mice infected with 5610
3 or 10
8 T. brucei AnTat 1.1 were killed on day 3 p.i.,
splenocytes collected and T1 (left) and T2 (right) transitional B cell apoptosis measured. Data are represented as mean of 3 mice 6 SEM (**) p,0,01.
doi:10.1371/journal.ppat.1002089.g005
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independently from the cyclooxygenase pathway
Besides TNF and Fas, also prostaglandins have been implicated
in B-cell apoptosis, in particular in a (intracellular) T. cruzi
infection setting [28]. To examine the possible contributions of
cyclo-oxygenase (COX) products to T. brucei-induced transitional
B cell death in vivo, indomethacin (a nonsteroidal anti-inflamma-
tory drug that inhibits COX activity), or control physiological
buffer, was administered daily to infected mice by i.p. injection
using a previously described protocol [52]. The indomethacin
Figure 6. Transitional T1 and T2 B cells in T. brucei-infected C57Bl/6 WT versus TNF
2/2 mice. Percentage of total transitional T1 (left) and
T2 (right) B cells in the spleen of uninfected controls (100%) versus T. brucei-infected C57BL/6 WT and TNF
2/2 mice on day 10, 20 and 30 p.i. Data are
represented as mean of three mice per group 6 SEM and three independent repeat experiments were performed.
doi:10.1371/journal.ppat.1002089.g006
Figure 7. CD95 (Fas) expression on T1 and T2 transitional B cells. (A) CD95 expression (black line) on transitional T1 and T2 B cells versus
isotype control (gray line) in uninfected mice and infected mice on day 14 of infection. (B) Percentage of CD95 expression on transitional T1 (left) and
T2 (right) B cells in C57BL/6 WT mice on day 8, 10, 14 and 20 p.i. Data are represented as mean of three mice per group 6 SEM and two independent
repeat experiments were performed (**) p,0,01.
doi:10.1371/journal.ppat.1002089.g007
T. brucei Infection-Induced B Cell Dysfunction in Mice
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infected mice with respect to transitional B cell apoptosis (Figure
S5). In a second set-up T. brucei-infected mice received
indomethacin in the drinking water at a concentration of 14 mg/
ml [53]. Here again, no difference was observed in the percentage
of transitional B cells undergoing apoptosis between treated mice
and untreated mice (data not shown).
In addition to the in vivo analysis of prostaglandin contribution to
the induction of transitional B cell apoptosis, an in vitro assay was
designed to further examine the contribution of cyclooxygenase
products to transitional B cell apoptosis. Here, spleen cells from
uninfected mice were co-cultured in a Trans-well system [29] with
spleen cells from uninfected miceor from mice that had been infected
for varying times with T. bruceiAntat 1.1. Culture conditions included
incubations in the presence or absence of trypanosomes and of
indomethacin. However, in none of the experimental conditions was
there a difference in percentage of transitional B cells undergoing
apoptosis compared to the controls(representative data are presented
in Figure S6), leading us to conclude that prostaglandins (either host
or parasite derived) are not a major contributor to transitional B-cell
apoptosis during T. brucei infections.
Apoptosis of transitional B cells is blocked when cell-cell
contact between trypanosomes and lymphocytes is
prevented
When performing the Trans-well experiments described above
to address the potential role of prostaglandins in transitional B cell
apoptosis, control conditions included co-cultures in which
parasites and splenocytes (either from uninfected or day 5 T.
brucei AnTat 1.1 infected mice) were not separated by a physical
barrier. In line with previous results obtained in co-cultures of
bloodstream form trypanosomes and B-cell hybridoma cells raised
against VSG [49], here the T1/2 transitional B-cell population
survival was significantly impaired, which was not observed when
parasites and B-cells were separated by a 0,4 mm polycarbonate
transmembrane. Indeed, Figure 9A (columns 1 and 2) shows that
incubation of spleen cells from uninfected mice with freshly
isolated living trypanosomes (10 trypanosome/spleen cell) resulted
in 75% lower survival of T1 and T2 B cells relative to incubation
in medium. In contrast, there was no difference in the numbers of
viable IgM
2ve B220
2ve leukocytes recovered from splenocytes
cultured in the presence or absence of trypanosomes (data not
shown).
Similarly, when spleen cells from mice infected 5 days earlier
with T. brucei were incubated with trypanosomes, there was a 50%
reduction in viable T1 and T2 B cells relative to cells cultured in
medium (Figure 9A columns 3 and 4) and again no reduction in
the recovery of IgM
2ve B220
2ve leukocytes (data not shown).
However, when cultured cells and trypanosomes were separated
by a 0.4 mm polycarbonate transmembrane there was no decrease
in the number of viable transitional B cells in the culture (Figure 9A
column 5) indicating that B cell loss does not result from diffusible
trypanosome products or from consumption of essential medium
components by living trypanosomes, but from the direct contact
Figure 8. In vivo anti-FasL treatment of T. brucei infected mice. Mice infected with T. brucei were treated with 100 mg of anti-FasL antibody on
days 4, 5 and 6 of infection and on day 7 of infection flow cytometric analysis was performed. (A) FACS plot from transitional T1, T2 and T3 B cells,
detected as (AA4.1
+B220
+) and respectively IgM
+CD23
2, IgM
+CD23
+ and IgM
loCD23
+ in infected but untreated control mice (left FACS panel), and
infected anti-FasL treated mice (right FACS panel). (B) Representative histogram of percentage of apoptotic cells within T1 (left) and T2 (right)
transitional B cell populations in uninfected controls (gray area) versus uninfected but treated mice (thin black line) and infected treated mice (thick
black line). Data are represented as mean of five mice per group 6 SEM.
doi:10.1371/journal.ppat.1002089.g008
T. brucei Infection-Induced B Cell Dysfunction in Mice
PLoS Pathogens | www.plospathogens.org 8 June 2011 | Volume 7 | Issue 6 | e1002089between the cells and the parasites. Culturing splenocytes from 5
day-infected mice with parasite lysate, or purified soluble VSG
(sVSG) from the parasites, rather than living parasites, also did not
result in the loss of transitional B cells (Figure 9B, columns 1–3).
To further examine whether contact with VSG on living T. brucei is
required for depletion of transitional B cells in vitro, T. brucei AnTat
1.1 trypanosomes were pre-incubated with a VSG-specific Nano-
body (Nb, a dromedary heavy chain antibody fragment, devoid of
its Fc part, having no detrimental effect on parasite survival [50]),
prior to addition to spleen cells from 5 day-infected mice. A
comparison of Figure 9B column 4 (control) and column 5 (Nb)
shows that the pre-treatment of trypanosomes with nanobodies
prevented the killing of B cells. Thus, these results corroborate the
obtained Trans-well results indicating that VSG dependent direct
contact between intact living trypanosomes and transitional B-cells
can trigger cell death.
Discussion
Infection with African trypanosomes causes mice and other
trypanosomiasis-susceptible mammals to develop non-specific
hypergammaglobulinemia and polyclonal activation that in the
end leads to B cell clonal exhaustion [10–12]. While the
mechanisms underlying B cell clonal exhaustion have yet to be
resolved, results by Radwanska et al. showed that the mature
marginal zone and follicular B cell populations rapidly disappear
during experimental trypanosome infections and that vaccine-
induced B-cell memory is destroyed in a non-specific manner [9].
Additional results suggested that while trypanosome infection
initially leads to rapid immune activation and buildup of
trypanosome/VSG-specific immunity against trypanosomes in
the initial parasitemic wave, humoral immune responsiveness is
rapidly lost. Impairment in the replacement and recruitment of
naı ¨ve B-cells to the spleen apparently prevents the efficient
activation of specific immunity later on in infection [47,48]. In
order to gain insight into the mechanisms of infection-induced B-
cell dysfunction, we have examined how T. brucei infection affects
B cell development in the bone marrow and the survival and
maturation of B cells in the periphery. Our studies show that BM
lymphopoiesis is shut down during infection and that compensa-
tory extramedullary B lymphopoiesis is truncated by apoptosis of
transitional B cells thus preventing replenishment of mature
marginal zone and follicular B cell compartments.
Mice infected with T. brucei exhibit reduced numbers of B cells
at all developmental stages in the bone marrow and transitional
stages in the spleen. Within the bone marrow, loss of CLP
preceded that of other progenitor populations raising the
possibility that downstream losses resulted from depletion of this
precursor population. However, if the loss of CLP was solely
responsible for the downstream disrupted B cell development, then
the ratio of a subsequent B cell developmental population to its
immediate upstream progeny and downstream precursors should
remain unaffected, which was not the case. Hence, additional
processes besides progenitor depletion must be operating to limit B
cell development in T. brucei infected mice.
Although aberrant differentiation, apoptosis and expulsion
from the bone marrow may singly or jointly contribute to loss of
B cell precursors from the bone marrow, we favor the latter
mechanisms based on the following arguments: (1) during
infection we could not measure any increase in B cell
precursor apoptosis in the bone marrow (Figure S7), (2)
alterations in the expression of essential B cell development-
specific transcription factors in the BM like Icaros, PU.1, EBF
and E2A and the IL-7 growth factor have never been reported
and were not observed in our laboratory either (data not shown),
(3) a reduction in bone marrow CXCL12 expression was the
only parameter found by us to correlate with the observed loss
of developing B cells during infection (Figure S8). The
importance of this result is underlined by the knowledge that
inflammation-induced reductions in stromal bone marrow
Figure 9. In vitro co-culture of total spleen cells and trypanosomes. (A) Total number of viable (or poly caspases-negative) transitional B (T1
and T2) cells left after 20 h of co-culture of total spleen cells from uninfected mice, or mice on day 5 of infection, with live bloodstream form
trypanosomes or with medium only as control, or total spleen cells from uninfected mice and trypanosomes separated by a 0,4 mm polycarbonate
transmembrane.. Data are presented as mean of three mice per group 6 SEM and three independent repeat experiments were performed (**)
p,0,01, (***) p,0,001. (B) Total number of viable transitional B (T1 and T2) cells left after 20 h of co-culture of total spleen cells from mice on day 5 of
infection with trypanosome lysate, T. brucei soluble VSG (sVSG), live bloodstream form trypanosomes, live trypanosomes pre-incubated with VSG-
specific nanobodies or only medium as control. Data are presented as mean of three mice per group 6 SEM and two independent repeat
experiments were performed (**) p,0,01, (***) p,0,001.
doi:10.1371/journal.ppat.1002089.g009
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correlate with a premature lymphocyte efflux [20]; (4) there are
elevated numbers of HSC-LMPP and CLP as well as pre-pro-B,
pro-B, pre-B and immature B cells in the spleen, suggesting the
possibility of an increased influx of these cells. In addition,
during the early stage of infection small numbers of HSC-
LMPP, CLP, pre-pro-B, pro-B, pre-B and immature B cells were
also found in the blood, the liver, peritoneum and lungs and
small numbers of pro-B, pre-B and immature B cells were found
in the lymph nodes. Taking these findings and arguments
together, we hypothesize that during early T. brucei infections, B
cell precursors prematurely migrate out of the bone marrow as a
result of the initiation of inflammation, and at least in part home
to the spleen, allowing transient extramedullary B lymphopoiesis
to take place.
Despite the initiation of extramedullary B lymphopoiesis,
infection-induced loss of mature B-cells marks progressing
trypanosomiasis in experimental infections. Various factors, in
particular the induction of systemic inflammation, could contrib-
ute to this. Hence, we addressed the potential involvement of three
likely participants, i.e. TNF, Fas and prostaglandins, all previously
shown to be potentially involved in immune and B-cell
malfunctioning. Paradoxically, despite the presence of high
systemic TNF levels during infection [38] and the clear evidence
shown here that transitional B cell loss through apoptosis coincides
with elevation of Fas expression on both T1 and T2 B cells, our
results showed through the use of knock-out mice as well as anti-
FasL antibodies that neither the TNF- nor the Fas- death
pathways acting alone are responsible for transitional B cell
apoptosis in a T. brucei infection setting. In addition, despite the
reported production of prostaglandins by trypanosomes [29] and
macrophages in infected mice [54] inhibition of prostaglandin/
cyclooxygenase activity in T. brucei infected mice by administration
of indomethacin did not rescue transitional B cells, contrasting
with results obtained in T. cruzi infections [28]. However, as each
of the death pathways could be redundant in a multi-factorial
complex event such as infection-induced apoptosis, their in vivo
individual contribution to transitional B cell apoptosis in the T.
brucei infection model should not be formally excluded.
The absence of a clear role for the Fas apoptosis pathway in
T. brucei induced transitional B-cell death is particularly
surprising, taken that (i) Fas upregulation on these cells is
reported here to be a clear hallmark of progressing infection,
and (ii) that Fas-FasL B cell killing in the context of an infectious
disease has previously been described in the case of Trypansosoma
cruzi infections, which induce Fas-mediated fratricide of IgG
+ B
lymphocytes specific for parasite antigens but not self antigens
[27]. In addition, Fas-mediated cell death is known to be
important in the regulation of the immune response and T and
B lymphocyte homeostasis [35], where for instance Fas-FasL
mediated apoptosis plays a critical role in the mechanism for
negative selection of B cells [44,45] and the establishment of the
B cell repertoire in the memory compartment [46]. However,
despite the reported role for Fas in parasite-induced fratricide,
its contribution to the killing of virus-infected, damaged or
excess cells and its implication in various immunopathological
disorders [43,44,47], our study did not provide any evidence
functionally linking Fas upregulation and B cell apoptosis.
Indeed, treating infected mice three times (with daily interval)
with 100 mg of anti-FasL antibody just prior to peak infection, in
order to block in vivo the activation of the Fas death cascade did
not alter the kinetics at which the transitional B cell population
underwent apoptosis. It could be argued that the doses of anti-
FasL antibody used in this experiment do not functionally block
the activation of the Fas apoptosis pathway, however, when Lpr
mice are infected with T. brucei, transitional B cells are lost from
the spleen to the same extend as in the wild type mice (data not
shown), arguing once again against a major involvement of the
Fas-apoptosis pathway.
Having shown that T. brucei driven transitional B-cell apoptosis
occurs in a TNF-, Fas- and prostaglandin-independent manner,
our study next focused on a model system that could help to
functionally unravel infection-induced B-cell apoptosis. Interest-
ingly, since B cell apoptosis only occurs when living parasites are
administered to the mice, and not when mice are treated on a
daily basis by the injection of high doses of trypanosome lysate
(results not shown), the presence of a toxin or a super-antigen-like
activity by trypanosome molecules appears to be excluded. These
results are in sharp contrast to the superantigen-mediated death of
mature B cells in the case of Staphylococcus aureus, where injection
with the virulence factor protein A alone is enough to mimic
massive Fas and TNF-independent bacterial induced B cell death,
and cause a ‘hole’ in the immune repertoire recognizing the
pathogen [55,56]. Also, it is worth recalling that the in vivo
experiments presented in this study show that initiation of
transitional B cell apoptosis depends on the timing at which peak
levels of parasitemia are reached, which is a function of the
number of living bloodstream form parasites used for initiation of
the infection. This observation suggests a link between the
presence of high numbers of living parasites and the induction
of parasite-induced transitional B-cell apoptosis consistent with the
possibility that B cell hyper-stimulation, through multiple VSG
(variable surface glycoprotein - attached to the parasite surface)/
BCR (B cell antigen specific receptor - attached to the B-cell
surface) interactions, could be a major contributor to this process,
as might exposure of B cells to short-lived parasite products which
would be active only when directly delivered to the target cell.
With respect to BCR signaling, cross-linking of the BCR has been
well described to trigger apoptosis of T1 and T2 transitional B
cells, which can be ameliorated in the case of T2 B cells by anti-
apototic signaling through the BlyS receptor BR3. Transitional B
cells of the T2 type can also be rescued from BCR crosslinking-
induced apoptosis by T cell help [30–32,57,58]. However, T cell
suppression is one of the hallmarks of T. brucei infection [54],
making it likely that T2 transitional B cells in infected mice are
exposed to the parasites in the absence of proper survival-
stimulating T cell help. Of crucial importance is the notion that
membrane-bound antigens that can extensively engage BCRs
trigger rapid BCR-mediated apoptosis in a Fas-independent
manner [59]. Hence, in the context of trypanosome-B cell
interaction, the presence of 10 million identical VSG molecules
densely packed on the surface of the parasite could be responsible
for causing BCR receptor clustering on the surface of the
transitional B cells, leading to hyper-stimulation of the B cell
and TNF/Fas-independent cell death in the absence of proper T-
cell signaling. Avidity, due to multiple VSG/BCR interactions, in
this case would have a much higher impact than actual BCR
affinity/specificity for a given VSG.
Using an in vitro co-culture system of splenocytes and live
bloodstream form trypanosomes, we showed that direct contact
between the living parasites and host B cells can indeed trigger
the deletion of the latter. Depletion of T1 and T2 transitional B
cells was maximally induced with 10 trypanosomes per spleen cell
in culture but was observed with as few as 0.1 trypanosomes/
spleen cell in culture, with 50% depletion occurring at a ratio of
between 0.1 and 0.5 trypanosome/spleen cell (Figure S9). This
falls within the physiologic range in vivo for infections with T.
brucei AnTat 1.1, where the ratio of trypanosomes to viable
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cultures of trypanosomes and splenocytes in which contact
between the two is prevented using a Trans-well system or a
pre-incubation of the parasite with a VSG-specific Nanobody,
abrogation of transitional B cell deletion is observed. This result
mirrors a previous observation by Radwanska et al. where cell
death was triggered in IgM expressing hybridoma cells when
cultured in the presence of living trypanosomes [49]. Again, in
the co-culture system neither lysate, nor purified parasite VSG
could mimic the apoptosis-inducing effect of living parasites (nor
could anti-FasL or prostaglandin inhibition block the detrimental
effect of living trypanosomes). Together, these observations
strengthen the hypothesis that the direct interaction of B cells
with epitopes on T. brucei causes transitional B cell death.
Unfortunately we cannot evaluate Nanobody blockage of
transitional B cell apoptosis in vivo as these antibody fragments
are very rapidly cleared from the circulation by the kidneys [60].
Thus, although the mechanism of T. brucei-induced transitional B
cell depletion in vivo remains to be fully elucidated, we did observe
that living trypanosomes induce cell death in transitional B cells in
vitro through a contact-dependent mechanism. Micro-array
analysis of material from both hybridoma co-culture assays and
spleen-derived B-cell co-cultures with trypanosomes are now
underway in order to shed light on the signal cascades involved in
this contact triggered apoptosis.
Combined, our study provides evidence for trypanosomiasis-
induced apoptosis of transitional B cells in the spleen and it
proposes a mechanism for T. brucei-induced B cell clonal
exhaustion and loss of humoral immune competence in trypano-
somaisis-susceptible hosts. Under normal conditions the produc-
tion of high-affinity, antigen-specific, class-switched, antibodies
takes up to 10 days after immunization [61,62]. Here, in our
infection model, about 90% of the transitional B cells are
undergoing apoptosis by day 8 of infection, making the
replenishment of the mature marginal zone and follicular B cell
populations impossible and therefore obstructing efficient germinal
center reaction and the renewal of the plasma B cell pool. Since
parasite-specific antibodies are essential for parasite control,
inhibition of B cell maturation at the transitional stage is an
efficient evasive mechanism developed by the parasite to interfere
with the protective antibody responses of the host and establish a
sustained infection. It is important to stress here that our studies
are based on a mouse model system for African trypanosomiasis,
which manifests certain limitations. However, the results obtained
in this model provide guidelines for analysis of B cell pathology in
more relevant hosts including susceptible livestock species such as
cattle and goat, or the retention of immune function in natural
trypanotolerant animals such as the Cape Buffalo, which have a
sustained capacity to generate effective protective antibody
responses against T. brucei and other African trypanosomes during
chronic infection, thus, maintaining cryptic parasitemia with few
or no signs of disease [7]. Based on our findings and the earlier
data reported by Radwanska et al. [9], it would also be crucial to
investigate whether a similar B cell pathology occurs in T. brucei
infected humans. In this context, it would be interesting to
compare B cell pathology between T. brucei gambiense (manifesting a
chronic infection in humans with prolonged parasitemia control)
and T. brucei rhodesiense (manifesting an acute infection whereby
parasitemia control is lost very early) infected patients, where in
the latter it could be that rapid destruction of the B-cell
compartment is the underlying reason for failure of parasitemia
control, the rapid induction of systemic inflammation, and the
subsequent passage of the parasite through the blood-brain
barrier.
Materials and Methods
Ethics statement
The study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
Guidelines for the Use of Laboratory Animals in Research,
Teaching and Testing of the International Council for Laboratory
Animal Science. All animal work was approved by the appropriate
committee at the University of Massachusetts (IACUC protocol
#s 26-09-09/27-09-09 and 2010-0028) and at the Vrije
Universiteit Brussel (ethics committee protocol # 09-220-1).
Parasites and infection in mice
All mice were housed under barrier conditions. Male C57BL/6
wild type (Taconic, Germantown, NY), Lpr and TNF
2/2 C57BL/
6 mice (provided by VUB, Belgium) (7–9 week old) were infected
by intraperitoneal (i.p.) injection of 5000 exponentially growing
pleomorphic Trypanosoma brucei Antat 1.1 (EATRO 1125 stock)
[51]. Parasitemia was assessed in blood collected from the tail vein
during infection. Blood was diluted in RPMI (Gibco, Grand
Island, NY, USA) and the number of trypanosomes present in the
blood was estimated using a hemocytometer and a light
microscope.
Cell isolation and flowcytometric analysis
B cell populations were analyzed by flowcytometry. Both spleen
and bone marrow from femur and tibia were harvested from non-
infected control and infected mice at different time points of
infection. Cell suspensions were prepared in FACS buffer (1.0%
BSA [Sigma, St. Louis, MO] in DPBS) and red blood cells were
lysed using ACK lysis buffer (0.15M NH4Cl, 1.0 mM KHCO3,
0.1 mM Na2-EDTA). Non-specific binding sites were blocked
using Fc block (CD16/CD32 Fcc III/II, BD biosciences, San Jose,
CA) for 30 minutes at 4uC. Cells were washed twice with FACS
buffer and stained with biotin- or fluorochrome-conjugated
primary antibodies (see following section) for 30 minutes at 4uC.
After washing twice, cell suspensions stained with biotin-
conjugated antibodies were incubated with streptavidin-conjugat-
ed fluorochromes (listed in the text), which detects cell bound
biotinylated antibodies, and incubated for an additional 30
minutes at 4uC. Finally, cells were resuspended in FACS buffer
with 1 mg of 7-amino-actinomycin D (7AAD), a fluorescent DNA
dye that binds to membrane permeable dead or dying cells, (BD
biosciences). Analyses were performed using a FACS Canto II flow
cytometer (BD Biosciences) and data were processed using
FLOWJO software (Tree Star Inc., Ashland, OR). The total
number of cells in each population was determined by multiplying
the percentages of subsets within a series of marker negative or
positive gates by the total cell number determined for each tissue.
Antibodies and detection reagents
The following antibodies were added to 100 ml aliquots of 10
6
Fc-blocked leukocytes prepared as described above: 0.5 mg anti-
IL7ra-FITC (clone A7R34), 0.2 mg anti-IgM-PE (clone II/41),
0.2 mg anti-IgM PE-Cy7 (clone II/41), 0,25 mg hamster IgG2 k
isotype control (clone B81-3), 0.5 mg anti-CD11b-FITC (clone
M1/70; 0.5 mg/ml), 0.5 mg anti-CD23-FITC (clone B3B4),
0.5 mg anti-CD45R (B220)-FITC (clone RA3-6B2), 0.2 mgo f
anti-CD45R (B220)-PE-Cy7 (clone RA3-6B2), 0.2 mg anti-CD93–
PE (clone AA4.1), 0.2 mg of anti-CD93-APC (clone AA4.1), 0.5 mg
anti-CD95 –FITC (clone Jo2), 0.2 mg of anti-CD117 (ckit)-APC
(clone 2B8), purchased from eBioscience (San Diego, CA); 0.2 mg
anti-CD1d-PE (clone 1b1), 0.2 mg of anti-CD19-APC-Cy7 (clone
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CD45R (B220)-APC-Cy7 (clone RA3-6B2), 0.2 mg of streptavidin-
PerCP, 0.2 mg of streptavidin-PE-Texas Red, purchased from BD
Biosciences (Erembodegem, Belgium); 2 mg of each of the
following antibodies: CD3e, CD11b (Mac-1), Gr-1 (Ly-6G and
Ly-6C) and Ter-119 (Ly-76) from the Biotin-conjugated Mouse
Lineage Panel (BD Biosciences, San Jose, CA).
Flow cytometric analyses of apoptosis
Cells were stained as described in the previous section with
antibodies. For the polycaspases-based apoptosis assay, labeled
cells were further reacted with the FLICA
TM fluorescent inhibitor
of caspase-1, 23, 24, 25, 26, 27, 28 and 29, using the FAM
Poly Caspases Assay Kit for flow-cytometric analysis (Molecular
probes, Invitrogen, Leiden, the Netherlands).
In vivo anti-FasL treatment
Mice infected with T. brucei where treated i.v. with 100 mgo f
purified anti-FasL antibody (clone MFL3, purchased from BD
Biosciences) on days 4, 5 and 6 of infection and on day 7 of
infection total spleen cells were isolated from treated mice and
untreated controls and prepared for flowcytometric analysis as
described above.
Co-culture experiments with total spleen cells and live
trypanosomes
On day 5 of infection mice were sacrificed to collect blood. In
addition, total spleen cells were isolated from the infected mice and
uninfected control mice and prepared for cell culture as described
above. Trypanosomes were purified from the blood by anion
exchange chromatography according to the method of Lanham &
Godfrey [63]. Then, 10
6 total spleen cells were put in co-culture
with or without 10
7 (or fewer) live bloodstream form parasites at
37uC, 5% CO2 and 95% humidity in RPMI1640 medium
containing 10% FBS, 2 mM pyruvate, 0.2 mM 2-mercaptoetha-
nol, and penicillin/streptomycin under different experimental
conditions and 20 h later, the cells were stained for flowcytometric
analysis. Parasite lysate was prepared by 3 repeated cycles of
freezing at 280uC and thawing and used at indicated concentra-
tion. Soluble VSG (sVSG) was prepared through heat-shock
treatment of a purified trypanosome suspension, which forces
them to release their VSG molecules, followed by anion exchange
chromatography, and used at indicated concentrations. Nanobo-
dies against soluble trypanosome VSG were prepared as described
in [50], starting from an immune library of VHH fragments of
heavy chain dromedary antibodies, obtained after multiple
vaccination with T. brucei AnTat 1.1 VSG. Trypanosomes were
pre-incubated with Nanobody BankIt1413802 Nb_An05–04
HQ680968 (monovalent and devoid of an Fc chain; 15 mg/ml
medium ) at the indicated concentrations 1 hour prior to addition
to the splenocytes, and the antibody was included in culture
medium during subsequent incubations. Under these assay
conditions, binding of the Nanobody onto the trypanosome
surface did not result in altered parasite survival.
Statistical analysis
Statistical comparisons were performed by ANOVA and means
were compared using Tukey and Dunnett’s post test when p#0.05
(GraphPad Prism v.4.0, GraphPad Software Inc. San Diego, CA).
Supporting Information
Figure S1 HSC/LMPP and CLP gating strategy. Repre-
sentative plots obtained using bone marrow or spleen cells from
uninfected mice stained for HSC/LMPP and CLP cells as
described in table 1.
(TIF)
Figure S2 Developing and immature B cell gating
strategy. Representative plots obtained using bone marrow or
spleen cells from uninfected mice stained for pre-pro B, pro-B, pre-
B and immature B cells as described in table 1.
(TIF)
Figure S3 Transitional and splenic mature B2 B cell
gating strategy. Representative plots obtained using spleen cells
from uninfected mice stained for Transitional T1, T2 and T3 B
cells and mature MZB and FoB cells as described in table 1.
(TIF)
Figure S4 CD95 (Fas) expression on T1 and T2 transi-
tional B cells in TNF
2/2 and TNF-R1
2/2 mice. (A)
Percentage of CD95 expression on transitional T1 (left) and T2
(right) B cells in C57Bl/6 WT mice versus TNF
2/2 mice in
uninfected controls and on day 14 pi. (B) Percentage of CD95
expression on transitional T1 (left) and T2 (right) B cells in C57Bl/
6 WT mice versus TNF-R1
2/2 mice in uninfected controls and
on day 14 pi. Data are represented as mean of three mice per
group 6 SEM.
(TIF)
Figure S5 In vivo inhibition of the cyclooxygenase
pathway during T. brucei infection using indomethacin,
Indomethacin was administered to mice infected with T. brucei and
uninfected control mice by daily i.p. injection and on day 10 of
infection mice were sacrificed and an apoptosis assay was
performed. (A) Representative histogram of the amount of active
caspases inside T1 transitional B cells (upper panel) and T2
transitional B cells (lower panel). (B) Percentage of transitional T1
(left) and T2 (right) transitional B cells undergoing apoptosis. Data
are represented as mean of 2 mice per control group and 3 mice
per experimental group 6 SEM.
(TIF)
Figure S6 In vitro co-culture transwell system to
investigate the contribution of the cyclooxygenase
(COX) pathway in the induction of transitional B cell
apoptosis. Total spleen cells from uninfected mice were co-
cultured in a transwell system separated by a 0,4 mm polycarbon-
ate transmembrane, with either medium or uninfected cells as a
control or total spleen cells from mice 5 days post infection in the
absence or presence of indomethacin (a nonsteroidal anti-
inflammatory drug that inhibits COX activity) and/or trypano-
somes. (A) Representative plots of T1 (AA4.1
+ B220
+ IgM
hi
CD23
2) and T2 (AA4.1
+ B220
+ IgM
hi CD23
+) transitional B cells
cultured under the different conditions. (B) Percentage of
transitional B cells undergoing apoptosis in the different co-culture
conditions.
(TIF)
Figure S7 Percentage of developing B cell apoptosis in
bone marrow during T. brucei infection. Bone marrow cells
from non-infected mice and mice infected with T. brucei for 6–10
days were stained for surface markers commonly used to define
pre-pro-, pro- and pre-B cells (left) and immature B cells (right), as
described in table 1 and consecutively stained for flow cytometric
apoptosis detection by binding of Annexin V. Data are
represented as mean of three mice per group 6 SEM, two
independent repeat experiments were performed.
(TIF)
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during T. brucei infection BM was isolated and amplified
using intron-spanning primers specific for CXCL12 via Quanti-
tative PCR. Data were normalized to GAPDH expression and are
presented as relative expression compared to uninfected controls.
Data are represented as mean of 6 or 8 mice 6 SEM. (*) p,0,05,
(**) p,0,01.
(TIF)
Figure S9 In vitro co-culture of total spleen cells and
trypanosomes. Total number of poly caspases-negative transi-
tional B (T1 and T2) cells left after 20 h of co-culture of total
spleen cells from uninfected mice with live bloodstream form
trypanosomes or with medium only as control. Data are presented
as mean of three mice per group 6 SEM and three independent
repeat experiments were performed (**) p,0,01.
(TIF)
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